Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study

Misr University for Science and Technology3 enrolled

Overview

This randomized controlled pharmacokinetic based study will be carried out on patients with both sexes and various ages, plasma triglycerides levels, clinical health disorders and using different agents for treatment of their hyperlipidemia in order to access the optimal drug therapy with best cost effectiveness in the elderly cases under investigation.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hyperlipidemia; Mixed

Interventions

Ezetimibe 10mgDRUG

Effect of ezetimibe on hyperlipidemia on patients with diabetes mellites

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients of dyslipidemia with high triglyceride level (200 to 499 mg/100 ml). * Total cholesterol level more than 200 mg/100 ml * Male and female * Age 35 - 70 years Exclusion Criteria: * \- Hypersensitivity of drugs * Liver toxicity * -Patients suffering from renal dysfunction

Locations (1)

Misr University for science and technology

Giza, Egypt

Outcomes

Primary Outcomes

Reduction of Total cholesterol

reduction of LDL

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.